Dr. Reddy's Glimepiride Tablets 1mg Recall: Misprint Hazard
Dr. Reddy's recalls 1mg Glimepiride tablets due to potential misprint on labels. This could lead to incorrect dosing. Affected products have specific NDC and lot numbers. Contact for remedy details.
Lower-risk recall
Misprint on tablet
Contact the company
What happened, in plain English
Dr. Reddy's is recalling 1mg Glimepiride tablets that may have a misprint on the label. This could cause incorrect dosing if taken without proper understanding of the label. The recall affects prescription-only bottles sold in specific lots and locations. Read more at govinfonow.com/recall/32863-dr-reddy-s-glimepiride-tablets-1mg-recall-misprint-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/32863-dr-reddy-s-glimepiride-tablets-1mg-recall-misprint-hazard · Updated August 17, 2026 · FDA enforcement record: FDA #D-0313-2024
Cite this page
“Dr. Reddy's Glimepiride Tablets 1mg Recall: Misprint Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32863-dr-reddy-s-glimepiride-tablets-1mg-recall-misprint-hazard. Based on FDA recall #D-0313-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0313-2024%22&limit=1).
Why it’s dangerous
A misprint on the tablet label could lead to incorrect dosing if the user misreads the label. This might cause an unsafe medication dose, but the risk is low as it's a prescription-only product with specific labeling.
Who’s affected
Prescription holders of Glimepiride tablets with the specific NDC number 55111-320-05 and lots T2303609 or T2303610. People taking diabetes medication are most at risk if they misread the label.
How to tell if you have this one
Check for the NDC number 55111-320-05 and lot numbers T2303609 or T2303610 on the bottle. The product is sold in 500-count bottles, prescription-only, and manufactured in India.
- Brand
Dr. Reddy's- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Ongoing- Distribution
Nationwide- NDC
55111-320-30, 55111-320-01, 55111-320-05, 55111-320-79, 55111-320-78, 55111-321-30, 55111-321-01, 55111-321-05, 55111-321-79, 55111-321-78, 55111-322-30, 55111-322-01, 55111-322-05, 55111-322-79, 55111-322-78
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0312-2024 | Glimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-01; Lot: T2303622; Exp. 06/2026 Lot: T2303626; Exp. 06/2026 Lot: T2303627; Exp. 06/2026 Lot: T2303628; Exp. 06/2026 Lot: T2303629; Exp. 06/2026 | 59,336 bottles |
| D-0313-2024 | Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05; Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026 | 14,425 bottles |
What to do — step by step
Check Label
Look for the NDC number 55111-320-05 and lot numbers T2303609 or T2303610 on the bottle.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 27 days after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Dr. Reddy's recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0313-2024 (January 18, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0313-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.